MedTrace Logo

tDCS for Treatment of Depression in Parkinson's Disease

NCT02960464 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-11-10

No results posted yet for this study

Summary

Investigation of possible benefits of transcranial direct current stimulation (tDCS) as a treatment of depression in patients with Parkinson's Disease, through a randomized placebo-controlled clinical trial.

Conditions

Interventions

DEVICE

Transcranial direct current stimulation

DEVICE

Sham Transcranial direct current stimulation

Sponsors & Collaborators

  • Hospital Santa Marcelina

    lead OTHER

Principal Investigators

  • Maria Sheila Rocha, MD, PhD · Hospital Santa Marcelina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02960464 on ClinicalTrials.gov